Access to cancer medicines and clinical trials show stark variations across Europe – Science Codex

Lugano, Switzerland, 18 September 2020 – Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020. (1,2)
Countries in Western Europe run a higher number of clinical trials for novel cancer treatments than countries in Eastern and Central Europe, showed an an…

Click here to view the original article.